Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for MNMD

Stock Name	Mind Medicine Inc
Ticker	MNMD(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	CA60255C8850

Show aggregate MNMD holdings

News associated with MNMD

Blair William & Co. IL Takes $73,000 Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD): Blair William & Co. IL acquired a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 12,500 shares of the company’s stock, valued at approximately $73,000. Several other large investors have also […] - 2025-08-14 05:02:58
MindMed Reports Strong Q2 2025 Results: Mind Medicine (MindMed)(NASDAQ:MNMD) reported Q2 2025 results on July 31, 2025. The company maintained strong enrollment momentum across all three pivotal phase 3 trials for MM120 ODT, confirmed a cash position of $237.9 million as of Q2 2025, sufficient to fund operations throug - 2025-08-11 05:37:30
1 Reason to Buy MindMed (MNMD): Key PointsThe company must operate under strict regulations, as it is developing certain medicines based on psychedelic substances. - 2025-08-07 06:25:00
Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Oppenheimer: Oppenheimer assumed coverage on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a report released on Monday, MarketBeat.com reports. The brokerage issued an outperform rating and a $25.00 price objective on the stock. Other research analysts have also recently issued reports about the stock. Chardan Capital reissued a “buy” rating and set a […] - 2025-08-07 03:06:55
Mind Medicine (MindMed) (NASDAQ:MNMD) Given “Buy” Rating at Chardan Capital: Chardan Capital reissued their buy rating on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a research note released on Friday morning,Benzinga reports. Chardan Capital currently has a $20.00 price objective on the stock. Separately, Cantor Fitzgerald raised Mind Medicine (MindMed) to a “strong-buy” rating in a report on Tuesday, May 13th. Seven […] - 2025-08-04 02:48:46
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of “Buy” from Analysts: Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have been given an average recommendation of “Buy” by the nine ratings firms that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The […] - 2025-07-29 02:14:49
Teacher Retirement System of Texas Sells 3,345 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD): Teacher Retirement System of Texas decreased its stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 18.4% during the first quarter, HoldingsChannel reports. The firm owned 14,860 shares of the company’s stock after selling 3,345 shares during the quarter. Teacher Retirement System of Texas’ holdings in Mind Medicine (MindMed) were worth […] - 2025-07-22 04:12:51
Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Target Price at $25.50: Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus rating of “Buy” from the eleven analysts that are presently covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 1-year price […] - 2025-07-07 02:32:46
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of “Buy” from Brokerages: Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned an average rating of “Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average 12-month […] - 2025-06-09 02:34:47
Reviewing Mind Medicine (MindMed) (NASDAQ:MNMD) and PacificHealth Laboratories (OTCMKTS:PHLI): Mind Medicine (MindMed) (NASDAQ:MNMD – Get Free Report) and PacificHealth Laboratories (OTCMKTS:PHLI – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk. Analyst Recommendations This is a breakdown of […] - 2025-06-06 02:55:01
BNP Paribas Financial Markets Invests $74,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD): BNP Paribas Financial Markets purchased a new position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the 4th quarter, Holdings Channel reports. The fund purchased 10,631 shares of the company’s stock, valued at approximately $74,000. Several other institutional investors have also modified their holdings of the company. Ameriprise Financial Inc. bought […] - 2025-06-02 04:44:55
Northern Trust Corp Has $4.77 Million Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD): Northern Trust Corp raised its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 12.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 684,836 shares of the company’s stock after purchasing an additional 76,559 shares during the period. […] - 2025-05-22 04:20:53
Raymond James Financial Inc. Acquires Shares of 16,004 Mind Medicine (MindMed) Inc. (NASDAQ:MNMD): Raymond James Financial Inc. bought a new position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 16,004 shares of the company’s stock, valued at approximately $111,000. Several other institutional investors and hedge funds also recently bought and sold […] - 2025-05-14 04:22:48
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Bought by Wells Fargo & Company MN: Wells Fargo & Company MN raised its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 61.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 39,974 shares of the company’s stock after purchasing an additional 15,269 shares during the period. Wells Fargo & Company MN’s […] - 2025-05-07 04:18:53
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Legal & General Group Plc: Legal & General Group Plc cut its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 8.8% during the fourth quarter, HoldingsChannel reports. The fund owned 58,437 shares of the company’s stock after selling 5,639 shares during the period. Legal & General Group Plc’s holdings in Mind Medicine (MindMed) were worth $407,000 at […] - 2025-04-30 04:54:53
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $25.11 Consensus Target Price from Brokerages: Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been given an average rating of “Buy” by the thirteen ratings firms that are presently covering the firm, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 12-month […] - 2025-04-23 02:30:49
Bank of New York Mellon Corp Boosts Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD): Bank of New York Mellon Corp boosted its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 5.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 200,121 shares of the company’s stock after buying an additional 10,338 shares during the quarter. […] - 2025-03-24 05:08:53
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $26.33 Consensus Price Target from Brokerages: Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has received a consensus rating of “Buy” from the thirteen ratings firms that are covering the company, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average twelve-month target […] - 2025-03-04 04:22:57
Warren Buffett's State of the Market: In this podcast, Motley Fool analyst Tim Beyers and host Dylan Lewis discuss: - 2025-03-03 14:29:00
Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $26.33: Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have received a consensus recommendation of “Buy” from the thirteen research firms that are currently covering the stock, MarketBeat reports. Ten investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average […] - 2025-02-07 04:32:50
China Universal Asset Management Co. Ltd. Buys Shares of 15,549 Mind Medicine (MindMed) Inc. (NASDAQ:MNMD): China Universal Asset Management Co. Ltd. bought a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 15,549 shares of the company’s stock, valued at approximately $108,000. A number of other hedge funds have also made changes to their positions in […] - 2025-02-04 07:46:56

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) MNMD holdings

Date	Number of MNMD Shares Held	Base Market Value of MNMD Shares	Local Market Value of MNMD Shares	Change in MNMD Shares Held	Change in MNMD Base Value	Current Price per MNMD Share Held	Previous Price per MNMD Share Held
2025-11-12 (Wednesday)	49,907	USD 605,871	USD 605,871	129	USD -15,358	USD 12.14	USD 12.48
2025-11-11 (Tuesday)	49,778	USD 621,229	USD 621,229	0	USD 36,337	USD 12.48	USD 11.75
2025-11-10 (Monday)	49,778	USD 584,892	USD 584,892	128	USD 3,987	USD 11.75	USD 11.7
2025-11-07 (Friday)	49,650	USD 580,905	USD 580,905	0	USD 17,874	USD 11.7	USD 11.34
2025-11-06 (Thursday)	49,650	USD 563,031	USD 563,031	128	USD -7,958	USD 11.34	USD 11.53
2025-11-05 (Wednesday)	49,522	USD 570,989	USD 570,989	0	USD -23,275	USD 11.53	USD 12
2025-11-04 (Tuesday)	49,522	USD 594,264	USD 594,264	129	USD -12,776	USD 12	USD 12.29
2025-11-03 (Monday)	49,393	USD 607,040	USD 607,040	0	USD -94,341	USD 12.29	USD 14.2
2025-10-31 (Friday)	49,393	USD 701,381	USD 701,381	0	USD 40,009	USD 14.2	USD 13.39
2025-10-30 (Thursday)	49,393	USD 661,372	USD 661,372	645	USD 32,035	USD 13.39	USD 12.91
2025-10-29 (Wednesday)	48,748	USD 629,337	USD 629,337	258	USD 5,271	USD 12.91	USD 12.87
2025-10-28 (Tuesday)	48,490	USD 624,066	USD 624,066	0	USD 1,939	USD 12.87	USD 12.83
2025-10-27 (Monday)	48,490	USD 622,127	USD 622,127	0	USD 21,821	USD 12.83	USD 12.38

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MNMD by Blackrock for IE00BDZVHG35

Show aggregate share trades of MNMD

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 BUY 129 13.140 12.110 12.213 USD 1,575 7.99
2025-11-10 BUY 128 12.890 11.665 11.788 USD 1,509 7.93
2025-11-06 BUY 128 11.700 11.130 11.187 USD 1,432 7.89
2025-11-04 BUY 129 12.530 11.880 11.945 USD 1,541 7.83
2025-10-30 BUY 645 13.500 12.600 12.690 USD 8,185 7.72
2025-10-29 BUY 258 12.910 13.740 13.657 USD 3,524 7.68
2025-10-22 SELL -512 12.430 12.630 12.610 USD -6,456 7.50 Loss of -2,614 on sale
2025-10-20 BUY 256 13.160 14.300 14.186 USD 3,632 7.43
2025-10-17 BUY 639 13.650 13.860 13.839 USD 8,843 7.38
2025-10-15 BUY 1,016 12.660 13.055 13.016 USD 13,224 7.34
2025-10-03 BUY 903 12.560 12.760 12.740 USD 11,504 7.26
2025-10-02 BUY 129 12.220 12.452 12.429 USD 1,603 7.22
2025-09-30 BUY 258 11.790 12.000 11.979 USD 3,091 7.15
2025-09-26 BUY 258 10.670 10.760 10.751 USD 2,774 7.08
2025-09-25 BUY 258 9.770 10.300 10.247 USD 2,644 7.06
2025-09-18 BUY 131 9.480 9.810 9.777 USD 1,281 7.04
2025-09-17 BUY 393 9.570 10.040 9.993 USD 3,927 7.02
2025-07-17 SELL -258 8.880 8.880 8.880 USD -2,291 6.94 Loss of -500 on sale
2025-07-11 SELL -1,040 8.060 8.170 8.159 USD -8,485 6.90 Loss of -1,313 on sale
2025-07-02 BUY 7,150 7.080 7.200 7.188 USD 51,394 6.87
2025-06-25 BUY 258 6.840 7.190 7.155 USD 1,846 6.88
2025-06-11 BUY 262 7.400 8.050 7.985 USD 2,092 6.86
2025-06-10 BUY 262 7.890 8.195 8.164 USD 2,139 6.85
2025-06-04 SELL -131 7.650 7.920 7.893 USD -1,034 6.82 Loss of -141 on sale
2025-04-23 BUY 131 6.110 6.330 6.308 USD 826 6.84
2025-04-10 SELL -1,040 5.140 5.511 5.474 USD -5,693 7.05 Profit of 1,636 on sale
2025-04-08 SELL -130 4.890 5.750 5.664 USD -736 7.11 Profit of 189 on sale
2025-04-07 SELL -131 5.430 5.550 5.538 USD -725 7.15 Profit of 211 on sale
2025-04-04 SELL -660 5.430 5.550 5.538 USD -3,655 7.18 Profit of 1,085 on sale
2025-04-01 BUY 532 5.540 5.835 5.806 USD 3,089 7.24
2025-03-31 SELL -396 5.850 6.065 6.044 USD -2,393 7.27 Profit of 486 on sale
2025-03-21 BUY 3,800 6.720 6.825 6.814 USD 25,895 7.37
2025-03-14 SELL -1,920 6.350 6.650 6.620 USD -12,710 7.49 Profit of 1,663 on sale
2025-03-07 SELL -240 6.830 6.910 6.902 USD -1,656 7.65 Profit of 180 on sale
2025-03-04 SELL -120 6.230 6.265 6.261 USD -751 7.79 Profit of 183 on sale
2025-02-25 BUY 240 6.750 7.140 7.101 USD 1,704 8.04
2025-02-19 SELL -118 8.280 8.600 8.568 USD -1,011 8.09 Loss of -56 on sale
2025-02-13 BUY 354 8.650 9.180 9.127 USD 3,231 7.79
2025-02-12 BUY 118 8.510 8.671 8.655 USD 1,021 7.73
2025-02-11 BUY 472 8.235 8.490 8.464 USD 3,995 7.70
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	BUY	129	13.140	12.110	12.213	USD 1,575	7.99
2025-11-10	BUY	128	12.890	11.665	11.788	USD 1,509	7.93
2025-11-06	BUY	128	11.700	11.130	11.187	USD 1,432	7.89
2025-11-04	BUY	129	12.530	11.880	11.945	USD 1,541	7.83
2025-10-30	BUY	645	13.500	12.600	12.690	USD 8,185	7.72
2025-10-29	BUY	258	12.910	13.740	13.657	USD 3,524	7.68
2025-10-22	SELL	-512	12.430	12.630	12.610	USD -6,456	7.50 Loss of -2,614 on sale
2025-10-20	BUY	256	13.160	14.300	14.186	USD 3,632	7.43
2025-10-17	BUY	639	13.650	13.860	13.839	USD 8,843	7.38
2025-10-15	BUY	1,016	12.660	13.055	13.016	USD 13,224	7.34
2025-10-03	BUY	903	12.560	12.760	12.740	USD 11,504	7.26
2025-10-02	BUY	129	12.220	12.452	12.429	USD 1,603	7.22
2025-09-30	BUY	258	11.790	12.000	11.979	USD 3,091	7.15
2025-09-26	BUY	258	10.670	10.760	10.751	USD 2,774	7.08
2025-09-25	BUY	258	9.770	10.300	10.247	USD 2,644	7.06
2025-09-18	BUY	131	9.480	9.810	9.777	USD 1,281	7.04
2025-09-17	BUY	393	9.570	10.040	9.993	USD 3,927	7.02
2025-07-17	SELL	-258	8.880	8.880	8.880	USD -2,291	6.94 Loss of -500 on sale
2025-07-11	SELL	-1,040	8.060	8.170	8.159	USD -8,485	6.90 Loss of -1,313 on sale
2025-07-02	BUY	7,150	7.080	7.200	7.188	USD 51,394	6.87
2025-06-25	BUY	258	6.840	7.190	7.155	USD 1,846	6.88
2025-06-11	BUY	262	7.400	8.050	7.985	USD 2,092	6.86
2025-06-10	BUY	262	7.890	8.195	8.164	USD 2,139	6.85
2025-06-04	SELL	-131	7.650	7.920	7.893	USD -1,034	6.82 Loss of -141 on sale
2025-04-23	BUY	131	6.110	6.330	6.308	USD 826	6.84
2025-04-10	SELL	-1,040	5.140	5.511	5.474	USD -5,693	7.05 Profit of 1,636 on sale
2025-04-08	SELL	-130	4.890	5.750	5.664	USD -736	7.11 Profit of 189 on sale
2025-04-07	SELL	-131	5.430	5.550	5.538	USD -725	7.15 Profit of 211 on sale
2025-04-04	SELL	-660	5.430	5.550	5.538	USD -3,655	7.18 Profit of 1,085 on sale
2025-04-01	BUY	532	5.540	5.835	5.806	USD 3,089	7.24
2025-03-31	SELL	-396	5.850	6.065	6.044	USD -2,393	7.27 Profit of 486 on sale
2025-03-21	BUY	3,800	6.720	6.825	6.814	USD 25,895	7.37
2025-03-14	SELL	-1,920	6.350	6.650	6.620	USD -12,710	7.49 Profit of 1,663 on sale
2025-03-07	SELL	-240	6.830	6.910	6.902	USD -1,656	7.65 Profit of 180 on sale
2025-03-04	SELL	-120	6.230	6.265	6.261	USD -751	7.79 Profit of 183 on sale
2025-02-25	BUY	240	6.750	7.140	7.101	USD 1,704	8.04
2025-02-19	SELL	-118	8.280	8.600	8.568	USD -1,011	8.09 Loss of -56 on sale
2025-02-13	BUY	354	8.650	9.180	9.127	USD 3,231	7.79
2025-02-12	BUY	118	8.510	8.671	8.655	USD 1,021	7.73
2025-02-11	BUY	472	8.235	8.490	8.464	USD 3,995	7.70

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MNMD

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	171,977	0	548,601	31.3%
2025-09-18	126,483	40	486,340	26.0%
2025-09-17	138,690	1,410	577,586	24.0%
2025-09-16	170,047	0	470,279	36.2%
2025-09-15	120,414	0	343,273	35.1%
2025-09-12	174,826	500	476,128	36.7%
2025-09-11	140,155	772	292,779	47.9%
2025-09-10	160,383	7,052	504,893	31.8%
2025-09-09	143,766	19	349,635	41.1%
2025-09-08	138,318	42	402,047	34.4%
2025-09-05	134,601	8,324	506,112	26.6%
2025-09-04	164,474	0	500,471	32.9%
2025-09-03	103,599	481	310,670	33.3%
2025-09-02	131,826	33,495	453,068	29.1%
2025-08-29	345,367	51,132	968,659	35.7%
2025-08-28	267,271	5,682	826,613	32.3%
2025-08-27	83,430	1,100	324,403	25.7%
2025-08-26	81,446	939	409,513	19.9%
2025-08-25	284,888	5,325	1,326,257	21.5%
2025-08-22	105,061	675	716,831	14.7%
2025-08-21	84,960	10	358,239	23.7%
2025-08-20	113,335	877	343,179	33.0%
2025-08-19	70,993	985	270,946	26.2%
2025-08-18	124,552	410	448,220	27.8%
2025-08-15	98,959	1,329	301,292	32.8%
2025-08-14	117,161	2,144	408,790	28.7%
2025-08-13	231,982	3,631	500,304	46.4%
2025-08-12	171,616	2,072	823,123	20.8%
2025-08-11	196,938	1,675	627,060	31.4%
2025-08-08	184,676	325	550,187	33.6%
2025-08-07	152,822	60	382,203	40.0%
2025-08-06	143,711	1,477	342,465	42.0%
2025-08-05	191,818	446	555,364	34.5%
2025-08-04	182,427	35,147	570,384	32.0%
2025-08-01	262,349	27,304	675,786	38.8%
2025-07-31	194,217	456	523,837	37.1%
2025-07-30	128,062	8,953	329,458	38.9%
2025-07-29	353,508	1,661	950,207	37.2%
2025-07-28	156,156	120	342,661	45.6%
2025-07-25	113,277	2,780	611,924	18.5%
2025-07-24	129,830	2,868	511,437	25.4%
2025-07-23	121,621	1,561	435,693	27.9%
2025-07-22	171,693	2,099	575,626	29.8%
2025-07-21	588,157	7,637	1,659,752	35.4%
2025-07-18	235,589	3,310	586,921	40.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE